A survey in Nepalese patients with acute leukaemia: a starting point for defining financial toxicity of cancer care in low-income and middle-income countries

Lancet Haematol. 2020 Sep;7(9):e638-e639. doi: 10.1016/S2352-3026(20)30258-1.

Authors

Bishesh Sharma Poudyal¹, Sanjit Giri², Sampurna Tuladhar³, Samir Neupane³, Bishal Gyawali⁴

Affiliations

¹ Clinical Hematology and Bone Marrow Transplant Unit, Department of Medicine, Civil Service Hospital, Kathmandu, Nepal.
² Nepal Leukemia support Society, Kathmandu, Nepal.
³ Department of Pathology, Civil Service Hospital, Kathmandu, Nepal.
⁴ Department of Oncology, Department of Public Health Sciences and Division of Cancer Care and Epidemiology, Queen's University, Kingston, ON, Canada. Electronic address: bg.bishalgyawali@gmail.com.

PMID: 32853583
DOI: 10.1016/S2352-3026(20)30258-1

No abstract available

MeSH terms

Cost of Illness*
Developing Countries
Humans
Income
Leukemia, Myeloid, Acute / epidemiology*
Nepal / epidemiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / epidemiology*
Public Health Surveillance
Surveys and Questionnaires